AHEAD Medicine has developed a fully automated flow cytometry analysis platform (AHEAD-flow) that is 100 times faster than current method to diagnose hematological malignancies.
AHEAD Medicine has developed a fully automated flow cytometry analysis platform (AHEAD-flow) that is 100 times faster than current method to diagnose hematological malignancies.
"*" indicates required fields
